Literature DB >> 8739304

Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-beta and tumor necrosis factor-alpha in the pterygium.

L Kria1, A Ohira, T Amemiya.   

Abstract

Some fibroangiogenic factors have recently been shown to play potential roles in fibrovascular diseases. The aim of this study was to examine whether there is any relationship between growth factors and pterygium genesis. Twenty-three primary pterygia and 4 normal conjunctiva specimens were analyzed by indirect immunohistochemistry using specific antibodies against basic fibroblast growth factor (b-FGF), platelet derived growth factor (PDGF), transforming growth factor-beta (TGF-beta) and tumor necrosis factor-alpha (TNF-alpha). Positive immunostaining of these growth factors was located in the epithelial cells, endothelial cells of vessels, basement membranes of vessels and epithelium, fibroblasts and infiltrating inflammatory cells in the pterygium. In the normal conjunctiva, positive immunolabeling for TGF-beta and PDGF was much weaker than in the pterygium. We conclude that growth factors may interact directly or indirectly in the pathogenesis of pterygium although proof of this awaits further studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739304     DOI: 10.1016/s0065-1281(96)80038-9

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  41 in total

1.  Pterygium in Indonesia: prevalence, severity and risk factors.

Authors:  G Gazzard; S-M Saw; M Farook; D Koh; D Widjaja; S-E Chia; C-Y Hong; D T H Tan
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

2.  The role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygium.

Authors:  Timothy M Nolan; Nick DiGirolamo; Nitin H Sachdev; Taline Hampartzoumian; Minas T Coroneo; Denis Wakefield
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

3.  Topical dobesilate eye drops for ophthalmic primary pterygium.

Authors:  Pedro Cuevas; Luis A Outeiriño; Javier Angulo; Guillermo Giménez-Gallego
Journal:  BMJ Case Rep       Date:  2012-03-08

4.  Subconjunctival bevacizumab in the impending recurrent pterygia.

Authors:  Sezin Akca Bayar; Cem Kucukerdonmez; Ozlem Oner; Yonca A Akova
Journal:  Int Ophthalmol       Date:  2013-09-12       Impact factor: 2.031

5.  Prevalence of pinguecula and pterygium in a general population in Spain.

Authors:  E Viso; F Gude; M T Rodríguez-Ares
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

6.  Characterisation of myofibroblasts in fibrovascular tissues of primary and recurrent pterygia.

Authors:  A Touhami; M A Di Pascuale; T Kawatika; M Del Valle; R H Rosa; S Dubovy; S C G Tseng
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

7.  Chronic inflammatory cells and damaged limbal cells in pterygium.

Authors:  P Anguria; T Carmichael; S Ntuli; J Kitinya
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

8.  Prospective study of exclusive strontium-/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up.

Authors:  Iraklis Vastardis; Bojan Pajic; Richard H Greiner; Brigitte Pajic-Eggspuehler; Daniel M Aebersold
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

Review 9.  Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.

Authors:  Daisy Y Shu; Frank J Lovicu
Journal:  Prog Retin Eye Res       Date:  2017-08-12       Impact factor: 21.198

10.  Cyclooxygenase 2 expression in pterygium.

Authors:  Chun-Chi Chiang; Ya-Wen Cheng; Chien-Lin Lin; Huei Lee; Fuu-Jen Tsai; Sung-Huei Tseng; Yi-Yu Tsai
Journal:  Mol Vis       Date:  2007-04-27       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.